New team in protein separation
Alfa Laval and Millipore are to work together to supply tools for the recovery of biopharmaceutical proteins generated by cell culture and fermentation.
Alfa Laval and Millipore are to work together to supply tools for the recovery of biopharmaceutical proteins generated by cell culture and fermentation.
Pliva has continued its rapid expansion with the opening of a new R&D facility in the USA that will carry out formulation work on generic pharmaceuticals.
Roche has moved to settle its long-running legal dispute with USA-based Igen by acquiring the firm in a deal valued at around $1.4 billion (€1.22bn).
Degussa has acquired a stake in a company specialising in ionic liquids, an innovative technology that could provide a greener alternative to commonly used volatile organic solvents in the manufacture of pharmaceuticals.
Fujisawa has decided to build a new formulation plant for its recently launched antifungal Funguard with a capital investment of Y3.8 billion (€28m).